医薬品有効成分の世界市場 2020年：企業別・地域別・種類別・用途別市場予測

• 英文タイトル：Global Active Pharmaceutical Ingredient Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-00119 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、医薬品有効成分の世界市場を広く調査・分析し、今後の市場展望をまとめております。医薬品有効成分の種類別市場規模（合成API、バイオテックAPI、その他）、用途別市場規模（化学薬品、消臭、日常生活）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Teva、Roche、Johnson & Johnson、Novartis、Dr. Reddy’s Laboratories、Pfizer、Sun Pharmaceutical Industries、North China Pharmaceutical Group、Mylan、Aurobindo pharma、Zhejiang Medicine、Hisun Pharmacy、Boehringer Ingelheim GmbH、Shandong Xinhua Pharmaceutical、Biocon、DSM、Bayer、Cambrex、Johnson Matthey、BASF、North East Pharmaceutical、Lonza group、Lupin、Tian Yao、Shandong Lukang Pharmaceutical、Cipla、Jiangsu　Hengrui Medicine、Huahai Pharmaceutical、Albemarle、Haerbin Pharmaceutical Group ・地域別グローバル市場分析 2015年-2020年 ・医薬品有効成分の北米市場（アメリカ、カナダ、メキシコ） ・医薬品有効成分のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・医薬品有効成分のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・医薬品有効成分の南米市場（ブラジル、アルゼンチン） ・医薬品有効成分の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：合成API、バイオテックAPI、その他 ・用途別分析：化学薬品、消臭、日常生活 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Active Pharmaceutical Ingredient market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.3% in the forecast period of 2020 to 2025 and will expected to reach USD 83030 million by 2025, from USD 65040 million in 2019.

The Active Pharmaceutical Ingredient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Active Pharmaceutical Ingredient market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Active Pharmaceutical Ingredient market has been segmented into
Synthetic API
Biotech API
Other

By Application, Active Pharmaceutical Ingredient has been segmented into:
Chemical
Deodorant
Dailylife

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Active Pharmaceutical Ingredient market presented in the report. This section sheds light on the sales growth of different regional and country-level Active Pharmaceutical Ingredient markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Active Pharmaceutical Ingredient market.

The report offers in-depth assessment of the growth and other aspects of the Active Pharmaceutical Ingredient market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Active Pharmaceutical Ingredient Market Share Analysis
Active Pharmaceutical Ingredient competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Active Pharmaceutical Ingredient sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Active Pharmaceutical Ingredient sales, revenue and market share for each player covered in this report.

The major players covered in Active Pharmaceutical Ingredient are:
Teva
Roche
Johnson & Johnson
Novartis
Dr. Reddy’s Laboratories
Pfizer
Sun Pharmaceutical Industries
North China Pharmaceutical Group
Mylan
Aurobindo pharma
Zhejiang Medicine
Hisun Pharmacy
Boehringer Ingelheim GmbH
Shandong Xinhua Pharmaceutical
Biocon
DSM
Bayer
Cambrex
Johnson Matthey
BASF
North East Pharmaceutical
Lonza group
Lupin
Tian Yao
Shandong Lukang Pharmaceutical
Cipla
Jiangsu　Hengrui Medicine
Huahai Pharmaceutical
Albemarle
Haerbin Pharmaceutical Group

Among other players domestic and global, Active Pharmaceutical Ingredient market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Active Pharmaceutical Ingredient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Active Pharmaceutical Ingredient, with price, sales, revenue and global market share of Active Pharmaceutical Ingredient in 2018 and 2019.
Chapter 3, the Active Pharmaceutical Ingredient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Pharmaceutical Ingredient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Active Pharmaceutical Ingredient market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Active Pharmaceutical Ingredient sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Active Pharmaceutical Ingredient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Pharmaceutical Ingredient Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Synthetic API
1.2.3 Biotech API
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Pharmaceutical Ingredient Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chemical
1.3.3 Deodorant
1.3.4 Dailylife
1.4 Overview of Global Active Pharmaceutical Ingredient Market
1.4.1 Global Active Pharmaceutical Ingredient Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Dr. Reddy’s Laboratories SWOT Analysis
2.5.4 Dr. Reddy’s Laboratories Product and Services
2.5.5 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sun Pharmaceutical Industries SWOT Analysis
2.7.4 Sun Pharmaceutical Industries Product and Services
2.7.5 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 North China Pharmaceutical Group
2.8.1 North China Pharmaceutical Group Details
2.8.2 North China Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 North China Pharmaceutical Group SWOT Analysis
2.8.4 North China Pharmaceutical Group Product and Services
2.8.5 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan SWOT Analysis
2.9.4 Mylan Product and Services
2.9.5 Mylan Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aurobindo pharma
2.10.1 Aurobindo pharma Details
2.10.2 Aurobindo pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aurobindo pharma SWOT Analysis
2.10.4 Aurobindo pharma Product and Services
2.10.5 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zhejiang Medicine
2.11.1 Zhejiang Medicine Details
2.11.2 Zhejiang Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Zhejiang Medicine SWOT Analysis
2.11.4 Zhejiang Medicine Product and Services
2.11.5 Zhejiang Medicine Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Hisun Pharmacy
2.12.1 Hisun Pharmacy Details
2.12.2 Hisun Pharmacy Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Hisun Pharmacy SWOT Analysis
2.12.4 Hisun Pharmacy Product and Services
2.12.5 Hisun Pharmacy Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Boehringer Ingelheim GmbH
2.13.1 Boehringer Ingelheim GmbH Details
2.13.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Boehringer Ingelheim GmbH SWOT Analysis
2.13.4 Boehringer Ingelheim GmbH Product and Services
2.13.5 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Shandong Xinhua Pharmaceutical
2.14.1 Shandong Xinhua Pharmaceutical Details
2.14.2 Shandong Xinhua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Shandong Xinhua Pharmaceutical SWOT Analysis
2.14.4 Shandong Xinhua Pharmaceutical Product and Services
2.14.5 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biocon
2.15.1 Biocon Details
2.15.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Biocon SWOT Analysis
2.15.4 Biocon Product and Services
2.15.5 Biocon Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 DSM
2.16.1 DSM Details
2.16.2 DSM Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 DSM SWOT Analysis
2.16.4 DSM Product and Services
2.16.5 DSM Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bayer
2.17.1 Bayer Details
2.17.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bayer SWOT Analysis
2.17.4 Bayer Product and Services
2.17.5 Bayer Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Cambrex
2.18.1 Cambrex Details
2.18.2 Cambrex Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Cambrex SWOT Analysis
2.18.4 Cambrex Product and Services
2.18.5 Cambrex Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Johnson Matthey
2.19.1 Johnson Matthey Details
2.19.2 Johnson Matthey Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Johnson Matthey SWOT Analysis
2.19.4 Johnson Matthey Product and Services
2.19.5 Johnson Matthey Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 BASF
2.20.1 BASF Details
2.20.2 BASF Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 BASF SWOT Analysis
2.20.4 BASF Product and Services
2.20.5 BASF Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 North East Pharmaceutical
2.21.1 North East Pharmaceutical Details
2.21.2 North East Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 North East Pharmaceutical SWOT Analysis
2.21.4 North East Pharmaceutical Product and Services
2.21.5 North East Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Lonza group
2.22.1 Lonza group Details
2.22.2 Lonza group Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Lonza group SWOT Analysis
2.22.4 Lonza group Product and Services
2.22.5 Lonza group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Lupin
2.23.1 Lupin Details
2.23.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Lupin SWOT Analysis
2.23.4 Lupin Product and Services
2.23.5 Lupin Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.24 Tian Yao
2.24.1 Tian Yao Details
2.24.2 Tian Yao Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Tian Yao SWOT Analysis
2.24.4 Tian Yao Product and Services
2.24.5 Tian Yao Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.25 Shandong Lukang Pharmaceutical
2.25.1 Shandong Lukang Pharmaceutical Details
2.25.2 Shandong Lukang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.25.3 Shandong Lukang Pharmaceutical SWOT Analysis
2.25.4 Shandong Lukang Pharmaceutical Product and Services
2.25.5 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.26 Cipla
2.26.1 Cipla Details
2.26.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.26.3 Cipla SWOT Analysis
2.26.4 Cipla Product and Services
2.26.5 Cipla Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.27 Jiangsu　Hengrui Medicine
2.27.1 Jiangsu　Hengrui Medicine Details
2.27.2 Jiangsu　Hengrui Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.27.3 Jiangsu　Hengrui Medicine SWOT Analysis
2.27.4 Jiangsu　Hengrui Medicine Product and Services
2.27.5 Jiangsu　Hengrui Medicine Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.28 Huahai Pharmaceutical
2.28.1 Huahai Pharmaceutical Details
2.28.2 Huahai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.28.3 Huahai Pharmaceutical SWOT Analysis
2.28.4 Huahai Pharmaceutical Product and Services
2.28.5 Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.29 Albemarle
2.29.1 Albemarle Details
2.29.2 Albemarle Major Business and Total Revenue (Financial Highlights) Analysis
2.29.3 Albemarle SWOT Analysis
2.29.4 Albemarle Product and Services
2.29.5 Albemarle Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.30 Haerbin Pharmaceutical Group
2.30.1 Haerbin Pharmaceutical Group Details
2.30.2 Haerbin Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.30.3 Haerbin Pharmaceutical Group SWOT Analysis
2.30.4 Haerbin Pharmaceutical Group Product and Services
2.30.5 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Active Pharmaceutical Ingredient Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Active Pharmaceutical Ingredient Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Active Pharmaceutical Ingredient Manufacturer Market Share in 2019
3.3.2 Top 6 Active Pharmaceutical Ingredient Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Regions
4.1.1 Global Active Pharmaceutical Ingredient Sales and Market Share by Regions (2015-2020)
4.1.2 Global Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2015-2020)
4.2 North America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.3 Europe Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.5 South America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
5.1.1 North America Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
5.1.2 North America Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
5.2 United States Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5.3 Canada Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5.4 Mexico Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
6.1.1 Europe Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
6.1.2 Europe Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
6.2 Germany Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.3 UK Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.4 France Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.5 Russia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.6 Italy Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Active Pharmaceutical Ingredient Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2015-2020)
7.2 China Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.3 Japan Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.4 Korea Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.5 India Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.7 Australia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
8.1.1 South America Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
8.1.2 South America Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
8.2 Brazil Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.3 Argentina Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.3 Turkey Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.4 Egypt Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.5 South Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Active Pharmaceutical Ingredient Sales and Market Share by Type (2015-2020)
10.2 Global Active Pharmaceutical Ingredient Revenue and Market Share by Type (2015-2020)
10.3 Global Active Pharmaceutical Ingredient Price by Type (2015-2020)
11 Global Active Pharmaceutical Ingredient Market Segment by Application
11.1 Global Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
11.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
11.3 Global Active Pharmaceutical Ingredient Price by Application (2015-2020)
12 Market Forecast
12.1 Global Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate (2021-2025)
12.2 Active Pharmaceutical Ingredient Market Forecast by Regions (2021-2025)
12.2.1 North America Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.2 Europe Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.3 Asia-Pacific Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.4 South America Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.5 Middle East & Africa Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.3 Active Pharmaceutical Ingredient Market Forecast by Type (2021-2025)
12.3.1 Global Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2025)
12.3.2 Global Active Pharmaceutical Ingredient Market Share Forecast by Type (2021-2025)
12.4 Active Pharmaceutical Ingredient Market Forecast by Application (2021-2025)
12.4.1 Global Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2025)
12.4.2 Global Active Pharmaceutical Ingredient Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Active Pharmaceutical Ingredient Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Active Pharmaceutical Ingredient Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Active Pharmaceutical Ingredient Major Business
Table 9. Teva Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 10. Teva SWOT Analysis
Table 11. Teva Active Pharmaceutical Ingredient Product and Services
Table 12. Teva Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Active Pharmaceutical Ingredient Major Business
Table 15. Roche Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 16. Roche SWOT Analysis
Table 17. Roche Active Pharmaceutical Ingredient Product and Services
Table 18. Roche Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Active Pharmaceutical Ingredient Major Business
Table 21. Johnson & Johnson Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Active Pharmaceutical Ingredient Product and Services
Table 24. Johnson & Johnson Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Active Pharmaceutical Ingredient Major Business
Table 27. Novartis Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Active Pharmaceutical Ingredient Product and Services
Table 30. Novartis Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Major Business
Table 33. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 34. Dr. Reddy’s Laboratories SWOT Analysis
Table 35. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product and Services
Table 36. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Active Pharmaceutical Ingredient Major Business
Table 39. Pfizer Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Active Pharmaceutical Ingredient Product and Services
Table 42. Pfizer Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Major Business
Table 45. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 46. Sun Pharmaceutical Industries SWOT Analysis
Table 47. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product and Services
Table 48. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. North China Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 50. North China Pharmaceutical Group Active Pharmaceutical Ingredient Major Business
Table 51. North China Pharmaceutical Group Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 52. North China Pharmaceutical Group SWOT Analysis
Table 53. North China Pharmaceutical Group Active Pharmaceutical Ingredient Product and Services
Table 54. North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Mylan Basic Information, Manufacturing Base and Competitors
Table 56. Mylan Active Pharmaceutical Ingredient Major Business
Table 57. Mylan Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 58. Mylan SWOT Analysis
Table 59. Mylan Active Pharmaceutical Ingredient Product and Services
Table 60. Mylan Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Aurobindo pharma Basic Information, Manufacturing Base and Competitors
Table 62. Aurobindo pharma Active Pharmaceutical Ingredient Major Business
Table 63. Aurobindo pharma Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 64. Aurobindo pharma SWOT Analysis
Table 65. Aurobindo pharma Active Pharmaceutical Ingredient Product and Services
Table 66. Aurobindo pharma Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 68. Zhejiang Medicine Active Pharmaceutical Ingredient Major Business
Table 69. Zhejiang Medicine Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 70. Zhejiang Medicine SWOT Analysis
Table 71. Zhejiang Medicine Active Pharmaceutical Ingredient Product and Services
Table 72. Zhejiang Medicine Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Hisun Pharmacy Basic Information, Manufacturing Base and Competitors
Table 74. Hisun Pharmacy Active Pharmaceutical Ingredient Major Business
Table 75. Hisun Pharmacy Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 76. Hisun Pharmacy SWOT Analysis
Table 77. Hisun Pharmacy Active Pharmaceutical Ingredient Product and Services
Table 78. Hisun Pharmacy Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Major Business
Table 81. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 82. Boehringer Ingelheim GmbH SWOT Analysis
Table 83. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product and Services
Table 84. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Major Business
Table 87. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 88. Shandong Xinhua Pharmaceutical SWOT Analysis
Table 89. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product and Services
Table 90. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Biocon Basic Information, Manufacturing Base and Competitors
Table 92. Biocon Active Pharmaceutical Ingredient Major Business
Table 93. Biocon Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 94. Biocon SWOT Analysis
Table 95. Biocon Active Pharmaceutical Ingredient Product and Services
Table 96. Biocon Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. DSM Basic Information, Manufacturing Base and Competitors
Table 98. DSM Active Pharmaceutical Ingredient Major Business
Table 99. DSM Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 100. DSM SWOT Analysis
Table 101. DSM Active Pharmaceutical Ingredient Product and Services
Table 102. DSM Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Bayer Basic Information, Manufacturing Base and Competitors
Table 104. Bayer Active Pharmaceutical Ingredient Major Business
Table 105. Bayer Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 106. Bayer SWOT Analysis
Table 107. Bayer Active Pharmaceutical Ingredient Product and Services
Table 108. Bayer Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Cambrex Active Pharmaceutical Ingredient Type and Application
Table 110. Cambrex Active Pharmaceutical Ingredient Major Business
Table 111. Cambrex Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 112. Cambrex SWOT Analysis
Table 113. Cambrex Active Pharmaceutical Ingredient Product and Services
Table 114. Cambrex Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Johnson Matthey Basic Information, Manufacturing Base and Competitors
Table 116. Johnson Matthey Active Pharmaceutical Ingredient Major Business
Table 117. Johnson Matthey Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 118. Johnson Matthey SWOT Analysis
Table 119. Johnson Matthey Active Pharmaceutical Ingredient Product and Services
Table 120. Johnson Matthey Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. BASF Basic Information, Manufacturing Base and Competitors
Table 122. BASF Active Pharmaceutical Ingredient Major Business
Table 123. BASF Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 124. BASF SWOT Analysis
Table 125. BASF Active Pharmaceutical Ingredient Product and Services
Table 126. BASF Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. North East Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. North East Pharmaceutical Active Pharmaceutical Ingredient Major Business
Table 129. North East Pharmaceutical Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 130. North East Pharmaceutical SWOT Analysis
Table 131. North East Pharmaceutical Active Pharmaceutical Ingredient Product and Services
Table 132. North East Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Lonza group Basic Information, Manufacturing Base and Competitors
Table 134. Lonza group Active Pharmaceutical Ingredient Major Business
Table 135. Lonza group Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 136. Lonza group SWOT Analysis
Table 137. Lonza group Active Pharmaceutical Ingredient Product and Services
Table 138. Lonza group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Lupin Basic Information, Manufacturing Base and Competitors
Table 140. Lupin Active Pharmaceutical Ingredient Major Business
Table 141. Lupin Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 142. Lupin SWOT Analysis
Table 143. Lupin Active Pharmaceutical Ingredient Product and Services
Table 144. Lupin Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 145. Tian Yao Basic Information, Manufacturing Base and Competitors
Table 146. Tian Yao Active Pharmaceutical Ingredient Major Business
Table 147. Tian Yao Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 148. Tian Yao SWOT Analysis
Table 149. Tian Yao Active Pharmaceutical Ingredient Product and Services
Table 150. Tian Yao Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 151. Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Major Business
Table 153. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 154. Shandong Lukang Pharmaceutical SWOT Analysis
Table 155. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Product and Services
Table 156. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 157. Cipla Basic Information, Manufacturing Base and Competitors
Table 158. Cipla Active Pharmaceutical Ingredient Major Business
Table 159. Cipla Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 160. Cipla SWOT Analysis
Table 161. Cipla Active Pharmaceutical Ingredient Product and Services
Table 162. Cipla Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 163. Jiangsu　Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 164. Jiangsu　Hengrui Medicine Active Pharmaceutical Ingredient Major Business
Table 165. Jiangsu　Hengrui Medicine Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 166. Jiangsu　Hengrui Medicine SWOT Analysis
Table 167. Jiangsu　Hengrui Medicine Active Pharmaceutical Ingredient Product and Services
Table 168. Jiangsu　Hengrui Medicine Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 169. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 170. Huahai Pharmaceutical Active Pharmaceutical Ingredient Major Business
Table 171. Huahai Pharmaceutical Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 172. Huahai Pharmaceutical SWOT Analysis
Table 173. Huahai Pharmaceutical Active Pharmaceutical Ingredient Product and Services
Table 174. Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 175. Albemarle Basic Information, Manufacturing Base and Competitors
Table 176. Albemarle Active Pharmaceutical Ingredient Major Business
Table 177. Albemarle Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 178. Albemarle SWOT Analysis
Table 179. Albemarle Active Pharmaceutical Ingredient Product and Services
Table 180. Albemarle Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 181. Haerbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 182. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Major Business
Table 183. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 184. Haerbin Pharmaceutical Group SWOT Analysis
Table 185. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product and Services
Table 186. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 187. Global Active Pharmaceutical Ingredient Sales by Manufacturer (2018-2019) (K MT)
Table 188. Global Active Pharmaceutical Ingredient Revenue by Manufacturer (2018-2019) (USD Million)
Table 189. Global Active Pharmaceutical Ingredient Sales by Regions (2015-2020) (K MT)
Table 190. Global Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 191. Global Active Pharmaceutical Ingredient Revenue by Regions (2015-2020) (USD Million)
Table 192. North America Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (K MT)
Table 193. North America Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 194. North America Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 195. North America Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Table 196. Europe Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (K MT)
Table 197. Europe Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 198. Europe Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 199. Asia-Pacific Active Pharmaceutical Ingredient Sales by Regions (2015-2020) (K MT)
Table 200. Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 201. Asia-Pacific Active Pharmaceutical Ingredient Revenue by Regions (2015-2020) (USD Million)
Table 202. South America Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (K MT)
Table 203. South America Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 204. South America Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 205. South America Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Table 206. Middle East & Africa Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (K MT)
Table 207. Middle East & Africa Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 208. Middle East & Africa Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 209. Middle East & Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Table 210. Global Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 211. Global Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 212. Global Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (USD Million)
Table 213. Global Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 214. Global Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 215. Global Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 216. Global Active Pharmaceutical Ingredient Sales Forecast by Regions (2021-2025) (K MT)
Table 217. Global Active Pharmaceutical Ingredient Market Share Forecast by Regions (2021-2025)
Table 218. Global Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2025) (K MT)
Table 219. Global Active Pharmaceutical Ingredient Market Share Forecast by Type (2021-2025)
Table 220. Global Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2025)
Table 221. Global Active Pharmaceutical Ingredient Market Share Forecast by Application (2021-2025)
Table 222. Direct Channel Pros & Cons
Table 223. Indirect Channel Pros & Cons
Table 224. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Active Pharmaceutical Ingredient Picture
Figure 2. Global Sales Market Share of Active Pharmaceutical Ingredient by Type in 2019
Figure 3. Synthetic API Picture
Figure 4. Biotech API Picture
Figure 5. Other Picture
Figure 6. Active Pharmaceutical Ingredient Sales Market Share by Application in 2018
Figure 7. Chemical Picture
Figure 8. Deodorant Picture
Figure 9. Dailylife Picture
Figure 10. Global Active Pharmaceutical Ingredient Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Active Pharmaceutical Ingredient Sales Market Share by Manufacturer in 2019
Figure 31. Global Active Pharmaceutical Ingredient Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Active Pharmaceutical Ingredient Revenue Market Share by Regions (2015-2020)
Figure 38. Global Active Pharmaceutical Ingredient Revenue Market Share by Regions in 2018
Figure 39. North America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 40. Europe Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 42. South America Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 44. North America Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Figure 46. North America Active Pharmaceutical Ingredient Sales Market Share by Countries in 2018
Figure 47. North America Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2018
Figure 49. United States Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2019
Figure 55. Germany Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Active Pharmaceutical Ingredient Revenue Market Share by Regions 2019
Figure 63. China Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Active Pharmaceutical Ingredient Sales Market Share by Countries in 2019
Figure 70. South America Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2019
Figure 71. Brazil Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Active Pharmaceutical Ingredient Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Active Pharmaceutical Ingredient Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Active Pharmaceutical Ingredient Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Active Pharmaceutical Ingredient Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Active Pharmaceutical Ingredient Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Active Pharmaceutical Ingredient Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Active Pharmaceutical Ingredient Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Active Pharmaceutical Ingredient Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel

---